Home›Psychiatry› Probiotics modestly reduce depressive symptom severity in adults with clinical depression
Probiotics modestly reduce depressive symptom severity in adults with clinical depressionProbiotics may modestly reduce symptoms for people with depression
Frontiers in MedicinePublished October 7, 2026DOI ↗Editorial oversight: Dr. Ji-eun Park, MD · Brain, Mind & Pain
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Interpret probiotic benefit for depression as modest and inconclusive for response or remission.
This meta-analysis examined orally administered probiotics versus placebo or another non-probiotic control in adults with clinically diagnosed depressive disorders, with a total sample of 460 participants. The primary outcome, depressive symptom severity, showed a modest reduction with probiotics (SMD, -0.43; 95% CI, -0.73 to -0.12).
Secondary outcomes were inconclusive. Clinical response (RR, 0.75; 95% CI, 0.32 to 1.77) and remission (RR, 0.42; 95% CI, 0.08 to 2.19) did not show clear effects. All-cause discontinuation did not differ clearly between groups (seven RCTs; RR, 1.15; 95% CI, 0.67 to 1.98).
Safety evidence was limited and inconsistently reported. Serious adverse events were not reported, and tolerability was not reported. The authors note that the prediction interval for symptom severity included the null, and that evidence regarding clinical response, remission, and safety remained inconclusive.
Follow-up duration and setting were not reported, and funding or conflicts of interest were not reported. The authors suggest that probiotic supplementation may modestly reduce depressive symptom severity, particularly as an adjunct to established treatment, but the certainty of evidence is limited.
How this fits prior evidence
This meta-analysis extends prior coverage of probiotics beyond respiratory and infectious contexts. Previous findings showed that oral Lactobacillus and Bifidobacterium probiotics improve pulmonary function and reduce inflammatory markers in COPD, and that probiotics and postbiotics demonstrate anti-Candida activity in preclinical models. The current synthesis addresses a gap by evaluating probiotics specifically in clinically diagnosed depressive disorders, but the modest effect size and inconclusive secondary outcomes contrast with the clearer signals seen in some prior probiotic research. The prediction interval including the null further limits confidence.
Living with depression can feel like an uphill battle every day. While many people look for ways to manage their symptoms, the role of gut health in mental health is still being explored. A review of several trials looked at whether taking probiotics—beneficial bacteria—could help adults with diagnosed depressive disorders.
The researchers found that people who took probiotics saw a modest reduction in the severity of their depressive symptoms. However, the evidence was not as clear when looking at other goals, such as whether patients reached full remission or showed a significant clinical response. The data was also limited when it came to tracking side effects, as reports were inconsistent across the studies.
Because the results for remission and safety are still inconclusive, these findings suggest that probiotics might work best as a small addition to existing treatments rather than a standalone fix. If you are looking into supplements to help manage your mood, talk to your doctor to see how they might fit into your specific care plan.
What this means for you:
Probiotics may slightly reduce the severity of depression symptoms, but more research is needed on safety and remission.
Common questions
Can probiotics help with depression symptoms?
The study found that taking probiotics can lead to a modest reduction in the severity of depressive symptoms for adults. However, the results were not conclusive when measuring if patients reached full remission or showed a clear clinical response. It may be most helpful as an addition to your current treatment plan.
Are there side effects to taking probiotics for depression?
The evidence regarding side effects was limited and inconsistently reported across the studies. Because the safety data is currently inconclusive, you should speak with your doctor before starting a new supplement to ensure it is safe for your specific health needs.
Will probiotics help me get into remission?
The study was unable to provide a clear answer on whether probiotics help patients reach remission. While there was a modest reduction in symptom severity, the data for remission and clinical response remained inconclusive, meaning more research is needed to know for sure.
BackgroundProbiotic supplementation has been investigated as a potential adjunctive treatment for depressive disorders, but its clinical efficacy and safety remain uncertain. This systematic review and meta-analysis aimed to evaluate the effects of probiotics on depressive symptom severity, clinical response, remission, treatment discontinuation, and adverse events in adults with clinically diagnosed depressive disorders.MethodsThis systematic review and meta-analysis was conducted in accordance with PRISMA guidelines. PubMed, Embase, Web of Science, and the Cochrane Library were searched from inception to May 8, 2026. Randomized controlled trials (RCTs) evaluating orally administered probiotics against placebo or another non-probiotic control were included. Continuous outcomes were summarized as standardized mean differences (SMDs) using Hedges’ g, and dichotomous outcomes as risk ratios (RRs), with 95% confidence intervals (CIs). Random-effects models used restricted maximum likelihood estimation with Hartung–Knapp adjustment. Heterogeneity was assessed using Cochran’s Q, I2, and τ2, and robustness was examined using leave-one-out sensitivity analysis.ResultsNine RCTs involving 460 participants were included. Probiotic supplementation was associated with a modest reduction in depressive symptom severity (SMD, −0.43; 95% CI, −0.73 to −0.12; I2 = 46.8%; τ2 = 0.069). The 95% prediction interval ranged from −1.10 to 0.25. Leave-one-out estimates ranged from −0.52 to −0.38, with all 95% CIs excluding zero. No significant effect modification was detected across formulation, dose, duration, treatment context, diagnostic population, or outcome-rater subgroups. Clinical response and remission were available from one trial and remained inconclusive (RR, 0.75; 95% CI, 0.32–1.77; and RR, 0.42; 95% CI, 0.08–2.19, respectively). All-cause discontinuation did not differ clearly between groups (seven RCTs; RR, 1.15; 95% CI, 0.67–1.98). Adverse-event evidence was limited and inconsistently reported.ConclusionProbiotic supplementation may modestly reduce depressive symptom severity, particularly as an adjunct to established treatment. However, the prediction interval included the null, and evidence regarding clinical response, remission, and safety remained inconclusive. Larger, adequately powered RCTs with standardized clinically meaningful outcomes and strain-specific reporting are required.
